You are here



Co-organized by the Barcelona Medical Association (COMB), Barcelona Activa, Keiretsu Forum (international network of investors) and Biocat.


This is the Catalan fund’s third investment in a company, after Phyture Biotech and Enemce Pharma, since it was created in 2011.


In the life sciences, Eduard Batlle of IRB Barcelona will receive €2.5 millions in funding to continue with colorectal cancer research.


Scientists from the supercomputing arena around the world can submit applications through 7 October. Each grant can be for a maximum of €3,000 per person.


US-based St. Jude Medical has purchased 100% of Endosense, a pioneer in developing catheters with pressure-sensor technology for cardiac arrhythmias.


Most of the competitive calls for companies and public bodies will be opened in the third and fourth quarters of 2013.


Projects must focus on new treatments for the elderly, the use of new technology for pharmacovigilance, or the development of antibiotics.


One hundred private investors from the IESE network will hear the projects on 27 June under the framework of the MIHealth international clinical innovation congress at the Fira de Barcelona.


The top ten projects will be presented to investors interested in the healthcare sector on 27 July at the MIHealth congress.


The Marie Curie Actions call for proposals, deadline 14 August, is aimed at researchers with a doctorate or at least four years of experience.